ASYS compared with VNDA: revenue, margins and what each company keeps, and the suppliers and customers both name

ASYSAmtech Systems Inc

Mkt capRevenueRevenue

VNDAVanda Pharmaceuticals Inc.

Mkt capRevenueRevenue

Compare

ASYSAmtech Systems Inc

VNDAVanda Pharmaceuticals Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ASYS1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±18.7%▼−6.62%×0.35

VNDA

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±11.7%▲+1.25%×0.11

Q2 FY26±18.7%▲+0.49%×0.03

= impliedASYS realized, solidVNDA realized, hatchedOne scale, both sides: full bar = 19%× = |realized| ÷ impliedSource: market data

Q1 FY26

±13.3%

▼−14.11%

×1.06

Feb 12 '26±11.0%▼−17.63%×1.60

ASYSAmtech Systems Inc

11.56▲+4.29%· post 11.51

Mkt cap$200.0MRevenue$22MQ3 FY26Revenue$79MFY25

VNDAVanda Pharmaceuticals Inc.

3.82▲+6.39%· post 3.82

ClosedNov 6 '26

Mkt cap$231.0MRevenue$70MQ3 FY26Revenue$216MFY25

Compare

ClosedNov 6 '26

ASYSAmtech Systems Inc

VNDAVanda Pharmaceuticals Inc.

11.56▲+4.29%post 11.51

Price

3.82▲+6.39%post 3.82

$200.0M

Mkt cap

$231.0M

Q3 FY26$22M

Revenue

$70MQ3 FY26

FY25$79M

Revenue

$216MFY25

ASYS11.56▲+4.29%vsVNDA3.82▲+6.39%ClosedNov 6 '26